Related references
Note: Only part of the references are listed.Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
BRCA1/2 Germline Mutations and Their Clinical Importance in Turkish Breast Cancer Patients
Gulsah Cecener et al.
CANCER INVESTIGATION (2014)
High prevalence of BRCA1 founder mutations in Greek breast/ovarian families
I. Konstantopoulou et al.
CLINICAL GENETICS (2014)
SuSPect: Enhanced Prediction of Single Amino Acid Variant (SAV) Phenotype Using Network Features
Christopher M. Yates et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
MutationTaster2: mutation prediction for the deep-sequencing age
Jana Marie Schwarz et al.
NATURE METHODS (2014)
A Classification Model for BRCA2 DNA Binding Domain Missense Variants Based on Homology-Directed Repair Activity
Lucia Guidugli et al.
CANCER RESEARCH (2013)
Serbian high-risk families: extensive results on BRCA mutation spectra and frequency
Jelena Dobricic et al.
JOURNAL OF HUMAN GENETICS (2013)
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Kyriaki Michailidou et al.
NATURE GENETICS (2013)
GENETIC VARIATION OF THE BRCA1 AND BRCA2 GENES IN MACEDONIAN PATIENTS
I Maleva et al.
BALKAN JOURNAL OF MEDICAL GENETICS (2012)
Three novel BRCA1/BRCA2 mutations in breast/ovarian cancer families in Croatia
Sonja Levanat et al.
GENE (2012)
Guidelines for Splicing Analysis in Molecular Diagnosis Derived from a Set of 327 Combined In Silico/In Vitro Studies on BRCA1 and BRCA2 Variants
Claude Houdayer et al.
HUMAN MUTATION (2012)
Predicting the Functional Effect of Amino Acid Substitutions and Indels
Yongwook Choi et al.
PLOS ONE (2012)
The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population
Vida Stegel et al.
BMC MEDICAL GENETICS (2011)
EMMA, a Cost- and Time-Effective Diagnostic Method for Simultaneous Detection of Point Mutations and Large-Scale Genomic Rearrangements: Application to BRCA1 and BRCA2 in 1,525 Patients
Virginie Caux-Moncoutier et al.
HUMAN MUTATION (2011)
Predicting the functional impact of protein mutations: application to cancer genomics
Boris Reva et al.
NUCLEIC ACIDS RESEARCH (2011)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
Prateek Kumar et al.
NATURE PROTOCOLS (2009)
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
Francois-Olivier Desmet et al.
NUCLEIC ACIDS RESEARCH (2009)
Greek BRCA1 and BRCA2 mutation spectrum:: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients
Irene Konstantopoulou et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2:: Application in a Dutch cancer clinic setting
Annemarie H. van der Hout et al.
HUMAN MUTATION (2006)
A high proportion of founder BRCA1 mutations in Polish breast cancer families
B Górski et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure
HJ Yang et al.
SCIENCE (2002)
Founder mutations in the BRCA1 gene in polish families with breast-ovarian cancer
B Górski et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Share Paper
